LifeVantage

LifeVantage Corporation is an active publicly traded wellness and nutrigenomics direct-selling company operating at LifeVantage.com under the Nasdaq ticker LFVN. The company traces its operating business to 2003 and built its brand around Protandim, a dietary supplement line positioned around Nrf2, NRF1, and NAD "activation." LifeVantage's current product portfolio includes Protandim, the LifeVantage line of dietary supplements including the MindBody GLP-1 System, TrueScience skin, hair-care, and liquid collagen products, AXIO nootropic energy drink mixes, PhysIQ, and Petandim for dogs. In fiscal 2025, LifeVantage reported $228.5 million in total net revenue, up from $200.2 million in fiscal 2024.

LifeVantage operates through a multilevel direct-selling model using independent consultants. The company's 2025 annual report states that independent consultants sell products, enroll and educate new consultants, and can create multiple levels of compensation through a downline, while also stating that LifeVantage pays commissions only on product sales and not for enrolling consultants. LifeVantage reported approximately 51,000 active independent consultants as of June 30, 2025, compared with 49,000 a year earlier.

The company has recently updated its compensation structure. LifeVantage implemented its Evolve Compensation Plan in several markets beginning in 2023, expanded it to Canada, Mexico, and Europe in 2024, and launched optimized versions in additional markets in late 2024 and 2025. Its 2025 annual report described commissions and incentives expense of $102.3 million, or 44.7% of revenue, for fiscal 2025, compared with $85.9 million, or 42.9% of revenue, in fiscal 2024.

LifeVantage's regulatory and litigation history includes a 2017 FDA warning letter over disease-related claims made for Protandim and related Nrf2 materials, including claims involving cardiovascular disease, Alzheimer's, Parkinson's, skin cancer, and cancer prevention or treatment. The company also faced a 2018 distributor class action alleging that its MLM structure operated as an illegal pyramid scheme; a Utah federal court denied class certification in April 2022. A separate 2016 securities class action was dismissed with prejudice in 2017, with LifeVantage later reporting that the derivative actions tied to that matter were voluntarily dismissed without payment.

David Brown, President and CEO